Industry NewsClinical Diagnostics Thermo Fisher Scientific’s Oncomine Dx Target Test receives FDA approval
Industry NewsLife Sciences Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer
Application NoteCharacterization of hERG Channel Blockers Using the FLIPR Potassium Assay Kit on the FlexStation Multi-Mode Microplate Reader
Scientific PosterIn Vitro Potency Assessment of hERG Inhibitors: Cell-Based Thallium-Sensitive Fluorescence Assay vs. Automated Electrophysiology
Application NoteDetecting Phenotypical Subgroups in Breast Cancer using Multiplexed Protein Expression Analysis in Intact Tissue Sections
Scientific PosterAnalysis of a New High Throughput Screening Detection Technology for Rapid hERG Safety Testing using a Fluorescence Polarization Assay
Industry NewsTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer
